Ahead of the 140th session of WHO Executive Board, which starts on Monday the 23 of January, ReAct has developed and shared a briefing document on Antimicrobial resistance (AMR) for Member State missions in Geneva to consider.
The briefing focuses on the three requests made to the WHO at the United Nations General Assembly High-level Meeting on Antimicrobial Resistance (New York, 21 September 2016) where Member States made three major requests to the WHO and its partners:
- Finalizing the global development and stewardship framework on antimicrobial medicines and resistance;
- Support national action plans and other activities to counter antimicrobial resistance at the national, regional and global levels; and
- Provide consultation to the Secretary-General on an ad hoc interagency coordination group to provide practical advice on approaches to ensure effective action to address antimicrobial resistance.
In the briefing ReAct lays out key evidence, offers guiding principles, and suggests opportunities for policy action to tackle antimicrobial resistance, both directly and through the lens of related issues such as agenda items on the global shortages of medicines and vaccines; the follow-up on the report of the Consultative Expert Working Group on financing and coordination of R&D; the Global Vaccines Action Plan and on the implementation of Agenda 2030 for Sustainable development.